¹Division of Nuclear Medicine, Department of Radiology, University of Alabama at Birmingham Medical Center, Birmingham, AL, USA

²Gene Therapy Program, University of Alabama at Birmingham Medical Center, Birmingham, AL, USA

³Division of Rheumatology, Department of Internal Medicine, University of Alabama at Birmingham Medical Center, Birmingham, AL, USA

Hepatic sequestration of systemically administered adenoviral vectors reduces the number of viral particles available for delivery to other tissues. The biological basis of this phenomenon was investigated using a new in vivo technique which permitted imaging in real time. Recombinant adenovirus serotype 5 knob (Ad5K) was radiolabeled with the gamma-emitter ^99mTc (half-life = 6 h). Scatchard analysis of the ^99mTc-Ad5K showed specific, high-affinity binding to U293 cells (K_d = 1.4 ± 0.5 nM), demonstrating that the radiolabeling process had no effect on receptor binding. In vivo dynamic imaging with an Anger gamma camera revealed that the liver binding followed an exponential rise to maximum, with a measured 100% extraction efficiency. Initially, the liver binding capacity was 3.1 ± 0.4 g Ad5K, equivalent to approximately 17000 Ad5K molecules per liver cell. Liver binding was blocked by preincubation of Ad5K with neutralizing anti-Ad5K antibody; a 50% reduction in liver uptake was demonstrated by imaging. Unlabeled Ad5K was more effective in blocking liver uptake of ^99mTc-Ad5K, whereas irrelevant unlabeled Ad3K had no effect. Imaging data for the liver uptake studies were in agreement with biodistribution determined by removing and measuring tissues. These data demonstrated that in vivo imaging is a sensitive tool for measuring changes to liver tropism. Similar imaging techniques can be applied to adenovirus vectors to measure specific targeting for gene therapy.

adenovirus knob; imaging; ^99mTc